WAAA!

40 million unattended births, 2.8 million neonatel deaths with 1 million babies dying on the day they are born due to inadequate care and scarce human resources. The aims of WAAA! are in tune with the WHO and Unicef’s Every New Born Vision (2015 and the new sustainable development goal- 3.1: preventing avoidable newborn deaths. WAAA! (Wearable, Anytime, Anywhere, APGAR) comprises of APGAR education, a celleluar gateway and a 9 wearable. The Apgar scale is universal tool used to assess neonatal vital signs: Appearance, Pulse, Grimace, Activity & Respiratory. The system monitors newborns by proxy and when they are at most risk: the first minute, the first hour, the first day of life. Dangerous respiratory and pulse levels triggers the gateway box to send a SMS text alert to village health teams to activate an emergency response. WAAA has the capability to collect birth registration data and monitor regional neonatal trends/ initiatives for 0.32 per birth

The Medieval Kingdom of Sicily Image Database. A Tribute to Caroline Bruzelius

In 2021 a group of researchers and students on both sides of the Atlantic Ocean toasted ten years of The Medieval Kingdom of Sicily Image Database project (https://kos.aahvs.duke.edu/): a collection of historical images of medieval monuments in Southern Italy launched in 2011 in order to document the turbulent history of this highly stratified patrimony, images that testify to the cultural richness of the Italian South. Online since October 2016, the project was fostered by Caroline Bruzelius at Duke University (NC) and, if it has become an invaluable research and study tool, it is thanks to her charisma and her indefatigable enthusiasm in the face of new challenges, both of which have helped her become as much a leading light in the world of Digital Humanities as she had already become in the field of medieval architecture. The papers presented in this volume, authored by both scientific collaborators and students, are a tribute to her, to celebrate ten years of the project and ideally to reap the fruit of the ambitious and visionary idea that set it all in train

PHarmacist Avoidance or Reductions in Medical Costs in Patients Presenting the EMergency Department: PHARM-EM Study

Objectives:. To comprehensively classify interventions performed by emergency medicine clinical pharmacists and quantify cost avoidance generated through their accepted interventions. Design:. A multicenter, prospective, observational study was performed between August 2018 and January 2019. Setting:. Community and academic hospitals in the United States. Participants:. Emergency medicine clinical pharmacists. Interventions:. Recommendations classified into one of 38 intervention categories associated with cost avoidance. Measurements and Main Results:. Eighty-eight emergency medicine pharmacists at 49 centers performed 13,984 interventions during 917 shifts that were accepted on 8,602 patients and generated $7,531,862 of cost avoidance. The quantity of accepted interventions and cost avoidance generated in six established categories were as follows: adverse drug event prevention (1,631 interventions;$2,225,049 cost avoidance), resource utilization (628; $310,582), individualization of patient care (6,122;$1,787,170), prophylaxis (24; $22,804), hands-on care (3,533;$2,836,811), and administrative/supportive tasks (2,046; $342,881). Mean cost avoidance was$538.61 per intervention, $875.60 per patient, and$8,213.59 per emergency medicine pharmacist shift. The annualized cost avoidance from an emergency medicine pharmacist was $1,971,262. The monetary cost avoidance to pharmacist salary ratio was between$1.4:1 and $10.6:1. Conclusions:. Pharmacist involvement in the care of patients presenting to the emergency department results in significant avoidance of healthcare costs, particularly in the areas of hands-on care and adverse drug event prevention. The potential monetary benefit-to-cost ratio for emergency medicine pharmacists is between$1.4:1 and $10.6:1

Lessons learned from the eMERGE Network: balancing genomics in discovery and practice

The Electronic Medical Records and Genomics (eMERGE) Network, established in 2007, is a consortium of academic and integrated health systems conducting discovery and implementation research in translational genomics. Here, we outline the history of the network, highlight major impacts and lessons learned, and present the tools and resources developed for large-scale genomic analyses and translation into a clinical setting. The network developed methods to extract phenotypes from the electronic medical record to perform genome-wide and phenome-wide association studies. Recruited cohorts were clinically sequenced off a custom panel for targeted sequencing of variants and monogenic disease risks and returned to participants to investigate the impact of return of genomic results. After generating a 105,000 participant-imputed genome-wide association study (GWAS) dataset for discovery, the network enrolled and sequenced 24,998 participants. Integration of these results into the medical record and the effects of results on participants provided key lessons to the field. These learned lessons inform genetic research in diverse populations and provide insights into the clinical impact of return and implementation of genomic medicine using the electronic medical record. The lessons produced by the eMERGE Network can be utilized by other consortia as translational genomic medicine research evolves

Students' participation in collaborative research should be recognised

Letter to the editor